2024
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review
Jegede O, De Aquino J, Hsaio C, Caldwell E, Funaro M, Petrakis I, Muvvala S. The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review. Journal Of Addiction Medicine 2024, 18: 499-510. PMID: 39356620, PMCID: PMC11449257, DOI: 10.1097/adm.0000000000001356.Peer-Reviewed Original ResearchNonmedical opioid useOpioid use disorderOpioid useWithdrawal symptomsTreatment outcomesSymptoms prior to treatmentUse disorderRisk of precipitated withdrawalLow-dose buprenorphineSynthetic opioidsPotency synthetic opioidsConclusions Current evidencePrecipitated withdrawalRisk of overdoseDosing strategiesPharmacological interactionsClinical significanceDecreased riskWeb of ScienceOpioidInclusion criteriaCurrent evidenceClinical implicationsMOUDPain
2023
Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review
Carr M, Lou R, Macdonald-Gagnon G, Peltier M, Funaro M, Martino S, Masheb R. Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review. The American Journal Of Drug And Alcohol Abuse 2023, 49: 551-565. PMID: 37200510, PMCID: PMC10840392, DOI: 10.1080/00952990.2023.2207720.Peer-Reviewed Original ResearchConceptsOpioid use disorderExcess weight gainWeight gainMedication treatmentUse disordersType of MOUDBuprenorphine/naloxoneRetrospective chart reviewUse of methadoneBody mass indexModerate weight gainMOUD initiationChart reviewCohort studyOpioid useBuprenorphine/Mass indexMedication doseMethadone treatmentNonrandomized studyCase reportEthnic disparitiesPotential associationMOUDPatients
2022
Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review
Bommersbach T, Justen M, Bunting A, Funaro M, Winstanley E, Joudrey P. Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review. International Journal Of Drug Policy 2022, 112: 103931. PMID: 36563489, DOI: 10.1016/j.drugpo.2022.103931.Peer-Reviewed Original ResearchConceptsOpioid use disorderMOUD accessUse disordersPatient's perspectiveMajority of patientsTailoring of interventionsPatient-centered accessMOUD deliveryTreatment outcomesInclusion criteriaPatient's abilityMOUD servicesDimensions of accessElectronic databasesStudy characteristicsQualitative synthesisUnique articlesRural communitiesStudy sampleHealthcare systemCommunity-engaged researchAccess dimensionsMedicationsDisordersCOVID-19Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders
Martins B, Rutland W, De Aquino JP, Kazer BL, Funaro M, Potenza MN, Angarita GA. Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders. Current Addiction Reports 2022, 9: 647-659. PMID: 35990796, PMCID: PMC9376579, DOI: 10.1007/s40429-022-00432-9.Peer-Reviewed Original ResearchSubstance use disordersUse disordersCocaine use disorderWithdrawal symptomsAbuse liabilityMultiple substance use disordersOpioid use disorderRegulatory approval statusFurther clinical researchPotential abuse liabilityNegative subjective effectsClinical trial researchPharmacological treatmentStimulant medicationPossible treatmentReviewThis reviewTherapeutic potentialTrial researchClinical researchSubjective effectsKetamineDecrease useDisordersGabapentinoidsApproval status
2021
The role of social network support in treatment outcomes for medication for opioid use disorder: A systematic review
Kumar N, Oles W, Howell BA, Janmohamed K, Lee ST, Funaro MC, O'Connor PG, Alexander M. The role of social network support in treatment outcomes for medication for opioid use disorder: A systematic review. Journal Of Substance Use And Addiction Treatment 2021, 127: 108367. PMID: 34134871, PMCID: PMC9022048, DOI: 10.1016/j.jsat.2021.108367.Peer-Reviewed Original ResearchConceptsOpioid use disorderUse disordersTreatment outcomesMedication treatmentMOUD treatmentSystematic reviewOpioid use disorder treatmentSocial network supportPositive social support networksUse disorder treatmentPatients' oddsOpioid deathsPatient populationSuccessful treatmentOpioid epidemicInclusion criteriaResearch DatabaseElectronic research databasesHealthy behaviorsDisorder treatmentTools physiciansTargeted interventionsDisordersMedicationsTreatment
2019
Integration of care for HIV and opioid use disorder
Oldfield B, Muñoz N, McGovern M, Funaro M, Villanueva M, Tetrault J, Edelman E. Integration of care for HIV and opioid use disorder. AIDS 2019, Publish Ahead of Print: &na;. PMID: 30882491, PMCID: PMC6588508, DOI: 10.1097/qad.0000000000002125.Peer-Reviewed Original ResearchConceptsHIV care settingsCare settingsClinical benefitTreatment settingsSystematic reviewBuprenorphine/naloxoneOpioid use disorderProvision of medicationsIntegration of careAntiretroviral therapyOpioid useMedication adherencePROSPERO databaseOvid MEDLINETreatment strategiesObservational studyHIVUse disordersModerate riskBehavioral interventionsScreening strategyOUDRisk reductionTreatmentUnique studies